Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology
First Session, Forty-first Parliament, 2011-12
Chair: The Honourable KELVIN KENNETH OGILVIE
Wednesday, April 4, 2012
Wednesday, April 25, 2012
Thursday, April 26, 2012
Issue No. 14
Fourth, fifth and sixth meetings on:
Study on prescription pharmaceuticals in Canada
- Minutes of Proceedings - April 4, 2012
- Minutes of Proceedings - April 25, 2012
- Minutes of Proceedings - April 26, 2012
- Transcript (Evidence) of Proceedings - April 4, 2012 (50K)
- Transcript (Evidence) of Proceedings - April 25, 2012 (102K)
- Transcript (Evidence) of Proceedings - April 26, 2012 (96K)
WITNESSES
Wednesday, April 4, 2012
Health Canada:
Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB);
Barbara Sabourin, Director General, Therapeutic Products Directorate (TPD), HPFB;
Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, TPD, HPFB.
Office of the Auditor General of Canada:
Neil Maxwell, Assistant Auditor General;
Louise Dubé, Principal.
Wednesday, April 25, 2012
BIOTECanada:
Peter Brenders, President and Chief Executive Officer.
Hoffmann-La Roche Ltd.:
Nita Arora, Regional Head Affiliate Management, North America.
Rx&D:
Russell Williams, President;
Ken Hughes, Vice-President, Scientific and Regulatory Affairs.
Amgen Canada Inc.:
Dr. Clive Ward-Able, Executive Director, Research and Development.
Thursday, April 26, 2012
Canadian Stroke Consortium:
Dr. Mukul Sharma, Chairman of the Board.
Institutional Review Board Services:
Jack Corman, President.
Reformulary Group:
Helen Stevenson, President and Chief Executive Officer.
MEMBERS OF THE COMMITTEE
The Honourable Kelvin Kenneth Ogilvie, Chair
The Honourable Art Eggleton, P.C., Deputy Chair
and
The Honourable Senators:
Callbeck, Champagne, P.C., Cordy, *Cowan (or Tardif), Demers, Dyck, *LeBreton, P.C. (or Carignan), Martin, Merchant, Seidman, Seth, Verner, P.C.
*Ex officio members
(Quorum 4)
Changes in membership of the committee:
Pursuant to rule 85(4), membership of the committee was amended as follows:
The Honourable Senator Cordy replaced the Honourable Senator Campbell (March 29, 2012).